Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Valis

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Frontiers in Cell and Developmental Biology|January 23, 2023
Designing of SiO<sub>2</sub> mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: <i>Ex vivo</i> evaluation and determination of pro-inflammatory interferon and interleukin mRNA expressionYasir Mehmood, Hira Shahid, Kashif Barkat, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 22, 2022
Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activitiesZofia Chrienova, Eugenie Nepovimova, Rudolf Andrys, et al.
Toxins|December 1, 2020
Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin InhibitorsFernanda D Botelho, Marcelo C Dos Santos, Arlan da S Gonçalves, et al.
Multiple Sclerosis and Related Disorders|March 3, 2022
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech RepublicPavel Hradilek, Eva Meluzinova, Olga Zapletalova, et al.
Current Alzheimer Research|March 16, 2019
N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer's Disease TherapyEugenie Nepovimova, Jan Korabecny, Vendula Hepnarova, et al.
Drug Design, Development and Therapy|March 23, 2018
Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisoningsKamil Kuca, Jana Zdarova Karasova, Ondrej Soukup, et al.
Molecules (Basel, Switzerland)|April 30, 2021
The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-<i>O</i>-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental PigsJan Bures, Ilja Tacheci, Jaroslav Kvetina, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysisBruno Brochet, Raymond Hupperts, Dawn Langdon, et al.
Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.
Multiple Sclerosis and Related Disorders|July 3, 2021
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in CzechiaDominika Stastna, Ingrid Menkyova, Jiri Drahota, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Frontiers in Cell and Developmental Biology|January 23, 2023
Designing of SiO<sub>2</sub> mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: <i>Ex vivo</i> evaluation and determination of pro-inflammatory interferon and interleukin mRNA expressionYasir Mehmood, Hira Shahid, Kashif Barkat, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 22, 2022
Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activitiesZofia Chrienova, Eugenie Nepovimova, Rudolf Andrys, et al.
Toxins|December 1, 2020
Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin InhibitorsFernanda D Botelho, Marcelo C Dos Santos, Arlan da S Gonçalves, et al.
Multiple Sclerosis and Related Disorders|March 3, 2022
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech RepublicPavel Hradilek, Eva Meluzinova, Olga Zapletalova, et al.
Current Alzheimer Research|March 16, 2019
N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer's Disease TherapyEugenie Nepovimova, Jan Korabecny, Vendula Hepnarova, et al.
Drug Design, Development and Therapy|March 23, 2018
Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisoningsKamil Kuca, Jana Zdarova Karasova, Ondrej Soukup, et al.
Molecules (Basel, Switzerland)|April 30, 2021
The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-<i>O</i>-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental PigsJan Bures, Ilja Tacheci, Jaroslav Kvetina, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysisBruno Brochet, Raymond Hupperts, Dawn Langdon, et al.
Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.
Multiple Sclerosis and Related Disorders|July 3, 2021
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in CzechiaDominika Stastna, Ingrid Menkyova, Jiri Drahota, et al.
Pageof 11